EdgarLookup

Forte Biosciences, Inc. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
Duvall Martin J Chief Executive Officer Purchase 5,000 $4.34 $21,700 13,605 May 28, 2019
GRUBER HARRY E President, Science&Innovation Purchase 5,000 $4.56 $22,800 9,744 May 24, 2019
Jolly Douglas EVP, Research & Pharm Devel Award / Grant 732 $8.19 $5,995 393,478 Jun 8, 2018
Das Asha SVP & Chief Medical Officer Other 2,500 $8.50 $21,250 5,000 Dec 8, 2017
FOLETTA MARK G EVP & Chief Financial Officer Other 2,500 $8.50 $21,250 7,500 Dec 8, 2017
Duvall Martin J Chief Executive Officer Other 2,500 $8.50 $21,250 6,071 Dec 8, 2017
GRUBER HARRY E President, Research & Devel Other 2,500 $8.50 $21,250 2,500 Dec 8, 2017
Jolly Douglas EVP, Research & Pharm Devel Other 739 $8.50 $6,282 392,043 Dec 8, 2017
Das Asha SVP & Chief Medical Officer Purchase 2,500 $10.00 $25,000 2,500 Apr 19, 2017
FOLETTA MARK G EVP & Chief Financial Officer Purchase 5,000 $10.00 $50,000 5,000 Apr 19, 2017
GRUBER HARRY E President, Research & Devel Purchase 25,000 $10.00 $250,000 417,753 Apr 19, 2017
Duvall Martin J Chief Executive Officer Other 3,571 $10.00 $35,710 3,571 Apr 19, 2017
BERGER FRANKLIN M Other 25,335 $10.00 $253,350 25,335 Apr 19, 2017
SCHIMMEL PAUL Purchase 10,000 $10.00 $100,000 13,623 Apr 19, 2017
Hasnain Faheem Other 102,857 $10.00 $1,028,570 102,857 Apr 19, 2017